Logo

Merck KGaA Selects PRA's Remote Patient Monitoring Platform for Human Growth Hormone Treatment System

Share this

Merck KGaA Selects PRA's Remote Patient Monitoring Platform for Human Growth Hormone Treatment System

Shots:

  • Merck KGaA selects PRA’s remote patient monitoring platform to work in combination with its HGH treatment system
  • PRA’s remote patient monitoring platform will support Merck’s KGH system including its growlink (mobile app) and easypod connect (HCP platform) to monitor patient adherence- review injection history- and share information about the progress of patients with GHD
  • The addition of a patient monitoring platform to HGH treatments better facilitates patient engagement- helps HCPs to make better use of patient visits- and ensures the treatment is taken regularly and at the right dosage- optimizing treatment outcome and driving payer confidence

  Ref: Globe Newswire | Image: Merck KGaA

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions